Pharmacokinetics of Unboosted Atazanavir in Treatment-Experienced HIV-infected Children, Adolescents and Young Adults

HIV protease inhibitor use in pediatrics is challenging due to the poor palatability and/or toxicity of concomitant low-dose ritonavir. Atazanavir without ritonavir (unboosted) is not recommended for patients with prior virologic failure; a common problem for perinatally-infected adolescents. Atazan...

全面介紹

Na minha lista:
書目詳細資料
發表在:Pediatr Infect Dis J
Main Authors: Cressey, Tim R., Hazra, Rohan, Wiznia, Andrew, Foca, Marc, Jean-Philippe, Patrick, Graham, Bobbie, King, Jennifer R., Britto, Paula, Carey, Vincent J., Acosta, Edward P., Yogev, Ram
格式: Artigo
語言:Inglês
出版: 2016
主題:
Article
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC5106325/
https://ncbi.nlm.nih.gov/pubmed/27583590
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/INF.0000000000001320
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍